Robert Rehard - Nov 7, 2024 Form 4 Insider Report for REGAL REXNORD CORP (RRX)

Role
EVP and CFO*
Signature
/s/ Hugo Dubovoy Jr., as Power of Attorney
Stock symbol
RRX
Transactions as of
Nov 7, 2024
Transactions value $
-$279,317
Form type
4
Date filed
11/12/2024, 07:03 PM
Previous filing
Oct 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RRX Common Stock Options Exercise $160K +2.15K +6.84% $74.56 33.6K Nov 7, 2024 Direct F1, F2
transaction RRX Common Stock Options Exercise $182K +3.32K +9.88% $54.79 36.9K Nov 7, 2024 Direct F1, F2
transaction RRX Common Stock Tax liability -$621K -3.47K -9.41% $178.92 33.4K Nov 7, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RRX Stock Appreciation Rights Options Exercise $0 -2.15K -100% $0.00 0 Nov 7, 2024 Common Stock 2.15K $74.56 Direct F1, F3
transaction RRX Stock Appreciation Rights Options Exercise $0 -3.32K -100% $0.00 0 Nov 7, 2024 Common Stock 3.32K $54.79 Direct F1, F3
holding RRX Stock Appreciation Rights 2.16K Nov 7, 2024 Common Stock 2.16K $76.99 Direct F3
holding RRX Stock Appreciation Rights 7.73K Nov 7, 2024 Common Stock 7.73K $74.04 Direct F4
holding RRX Stock Appreciation Rights 15.4K Nov 7, 2024 Common Stock 15.4K $78.05 Direct F4
holding RRX Stock Appreciation Rights 12.3K Nov 7, 2024 Common Stock 12.3K $84.39 Direct F5
holding RRX Stock Appreciation Rights 9.28K Nov 7, 2024 Common Stock 9.28K $133.77 Direct F5
holding RRX Stock Appreciation Rights 8.29K Nov 7, 2024 Common Stock 8.29K $151.27 Direct F5
holding RRX Stock Appreciation Rights 9.46K Nov 7, 2024 Common Stock 9.46K $154.20 Direct F5
holding RRX Stock Appreciation Rights 7.66K Nov 7, 2024 Common Stock 7.66K $168.47 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of Stock Appreciation Rights ("SARs") expiring on May 12, 2025 and May 11, 2026. The underlying shares were retained, net of shares withheld to cover the SARs' exercise price and applicable taxes, as indicated in this Form 4.
F2 Amount beneficially owned reflects deduction of 73.712 dividend equivalent shares ("DSUs") associated with unearned performance share units that were inadvertently credited to the reporting person in previous Form 4 reports. These DSUs will be credited to the reporting person's beneficial ownership total when, if and as earned.
F3 Granted as stock-settled SARs under the 2013 Equity Incentive Plan. The SARs vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant.
F4 Granted as stock-settled SARs under the 2018 Equity Incentive Plan. The SARs vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant.
F5 Granted as stock-settled SARs under the 2018 Equity Incentive Plan. The SARs vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant.
F6 Granted as stock-settled SARs under the 2023 Omnibus Incentive Plan. The SARs vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant.

Remarks:

*Executive Vice President and Chief Financial Officer